Meeting | Mixed
Event Title
FDA Expert Panel on Testosterone Replacement Therapy for Men
December 10, 2025
- Date:
- December 10, 2025
The FDA encourages the public to comment in docket FDA-2025-N-6743 Expert Panel on Testosterone Replacement Therapy for Men.
Helen L. Bernie, DO, MPH
Associate Professor of Urology
Director of Male Sexual and Reproductive Medicine Program
Indiana University
ADM Brian Christine, MD
HHS Assistant Secretary for Health and
Head of the United States Public Health Service Commissioned Corps
MAJ Theodore Crisostomo-Wynne, MD
Urologist
Assistant Professor of Surgery
Madigan Army Medical Center
Michael C. Davis, MD, PhD
Deputy Director, FDA Center for Drug Evaluation and Research
Richard Iorio, MD
Principal Medical Advisor
Food and Drug Administration
Emeritus Professor, Harvard Medical School
Mohit Khera, MD, MBA, MPH
Professor of Urology
Baylor College of Medicine
Tobias S. Köhler, MD, MPH, FACS
Professor of Urology
Head of Men’s Health
Mayo Clinic, Rochester
Larry Lipshultz, MD
Professor of Urology
Chief, Division of Male Reproductive Medicine and Surgery
Baylor College of Medicine
Martin Miner, MD
Clinical Professor of Family Medicine & Urology
Co-Director Men’s Health Center
Alpert School of Medicine, Brown University
Abraham Morgentaler, MD, FACS
Blavatnik Faculty Fellow in Health and Longevity
Harvard University
John P. Mulhall, MD, MSc, FECSM, FACS, FRCSI
Director, Sexual & Reproductive Medicine, Urology Service at Memorial Sloan-Kettering Cancer Center
Shalin Shah
CEO, Marius Pharmaceuticals
Landon Trost, MD
Director of the Male Fertility and Peyronie’s Clinic, Laboratory and Procedural Services
Brigham Young University
Webcast Recording: FDA Expert Panel on Testosterone Replacement Therapy for Men - YouTube
Media Inquiries: HHS Press Office